Forecast & Rating2 analysts currently cover 60 Degrees Pharmaceuticals, of which 1 give a positive rating. The average price target is $3.70, about 227.4% upside from the current price of $1.13. Coverage is limited, so the data is for reference only. Data as of Aug 17, 2026; this does not constitute investment advice.
Aug 17, 2026Price forecast
$3.70227.43%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met0.0%
Stock price$1.13
Avg. target$3.7
High target$4
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.